A strength of this investigation is that the RAI is a validated measure of LH in patients with arthritis (28), and its concise nature is conducive to a high completion rate (97% of patients in this cohort completed the RAI at baseline). The gene discussed is PLOD1; the disease is arthritic joint disease.